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Abstract
Hypercalcaemic crisis is an uncommon and potentially life-threatening manifestation of primary hyperparathyroidism, and it is associated with 
rapid deterioration of the central nervous system, and cardiac, gastrointestinal, and renal function. We present the case of a 76 year-old man in 
a sudden coma due to hypercalcaemic crisis as a first manifestation of primary hyperparathyroidism. At first, the patient was treated conservatively, 
his mental status gradually improved in the next three days. On the ninth day after the initiation of therapy, a minimally invasive radio-guided 
parathyroidectomy was performed. Histologically, the tumour consisted of densely arranged chief cells immunohistochemically positive for 
PTH antigens, suggesting adenoma. Calcaemia level and PTH were normalised in the immediate postoperative period. A systematic review was 
performed by consulting PubMed MEDLINE for publications from 1958 to 2011. This review found a total of 499 reported cases of hypercalcaemic 
crisis due to primary hyperparathyroidism. Manifestations are neurological alterations, and cardiac, renal and gastrointestinal dysfunctions as-
sociated with markedly elevated serum calcium and parathyroid hormone levels. The most frequent histology is the parathyroid adenoma. In 
untreated cases, mortality is 100%. Despite advances in its management, the mortality rate is still 93.5% in patients treated only conservatively. 
Medical therapy followed by expeditious parathyroidectomy should be considered as the treatment of choice for patients affected by 
hypercalcaemic crisis due to a primary hyperparathyroidism. (Endokrynol Pol 2012; 63 (6): 494–502)
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Streszczenie
Przełom hiperkalcemiczny jest rzadkim choć potencjalnie zagrażającym życiu objawem pierwotnej nadczynności przytarczyc i jest skoja-
rzony z gwałtownym pogorszeniem funkcji ośrodkowego układu nerwowego, serca, przewodu pokarmowego i funkcji nerek. 
W pracy zaprezentowano przypadek 76-letniego mężczyzny, u którego pierwszym objawem pierwotnej nadczynności przytarczyc był 
przełom hiperkalemiczny w postaci nagłej śpiączki. Na początku pacjent był leczony zachowawczo i jego stan psychiczny zaczął ulegać 
stopniowej poprawie w ciągu pierwszych 3 dni. Dziewiątego dnia terapii wykonano u niego mini inwazyjny zabieg usunięcia przytarczyc 
pod kontrolą RTG. Histologicznie guz składał się z gęsto ułożonych dużych komórek pozytywnych badaniem imunohistologiczno-che-
micznym dla antygenów PTH, sugerując gruczolak. Stężenie wapnia i PTH znormalizowano w bezpośrednim okresie pooperacyjnym. 
Dokonano systematycznego przeglądu publikacji PubMed MEDLINE w latach 1958–2011. Przegląd zawiera łącznie 499 odnotowanych 
przypadków przełomu hiperkalcemicznego jako objawu pierwotnej nadczynności przytarczyc. Przejawy to zmiany neurologiczne, dys-
funkcja nerek, przewodu pokarmowego i serca związanych ze znacznie podwyższonym stężeniem wapnia i parathormonu w surowicy. 
W badaniu histologicznym najczęściej diagnozowany jest gruczolak przytarczycowy. W przypadkach nieleczonych odnotowuje się 
100-procentową śmiertelność. Mimo postępów w leczeniu, przy terapii tylko zachowawczej, śmiertelność jest nadal wysoka — 93,5%. 
Leczenie zachowawcze plus szybkie usuniecie przytarczyc powinny być uważane za leczenie z wyboru u pacjentów dotkniętych przeło-
mem hiperkalcemicznym z powodu pierwotnej nadczynności przytarczyc. (Endokrynol Pol 2012; 63 (6): 494–502)
Słowa kluczowe: przełom hiperkalcemiczny, pierwotna nadczynność przytarczyc, hiperkalcemia, przytarczyca, ostra nadczynność przytarczyc
Introduction
Serum calcium levels greater than 15 mg/dL (3.75 
mmol/L) associated with rapid deterioration of the cen-
tral nervous system, cardiac, gastrointestinal, and renal 
function depict the so-called hypercalcaemic crisis. This 
is an uncommon manifestation of severe calcium intoxi-
cation, requiring prompt diagnosis and rapid treatment 
in order to avoid a lethal course. Indeed, unless treated, 
the mortality rate is basically 100% [1, 2].
Hypercalcaemia, when compensated, is caused 
more frequently by malignancy, primary hyperparathy-
roidism (PHPT) and vitamin D-induced hypercalcae-
mia, and less frequently by thyrotoxicosis, drug-induced 
condition (e.g. thiazide diuretics, lithium, oestrogens 
and antioestrogens, androgens, vitamin A), immobilisa-
tion, tuberculosis, rabdomyolysis, sarcoidosis, milk-alka-
li syndrome, kidney disease and familial hypocalciuric 
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hypercalcaemia. However, the cause of hypercalcaemic 
crisis is PHPT in the majority of cases [2–5].
Generally, PHPT is found incidentally with no ap-
parent clinical manifestations, via simple laboratory 
tests. The simultaneous occurrence of hypercalcaemia 
and elevated (or non-suppressed) PTH level in fact 
proves the parathyroid origin of the disease. A patient 
rarely shows a severe hypercalcaemic crisis as his or her 
first manifestation of PHPT.
We present the case of a severe and sudden hypercal-
caemic crisis as a first presentation of PHPT secondary 
to a parathyroid adenoma.
Case report
A 76 year-old man was admitted as an emergency 
to the Department of Neurology due to a sudden 
syncopal episode that lapsed into coma. Anamnesis 
revealed that the patient was in good general health, 
and did not take vitamin supplements, lithium or 
thiazide diuretics. He had had polyuria of two weeks’ 
duration prior to admission. Endocrinologic family 
history was uneventful.
On physical examination, the patient presented se-
vere dehydration, but his blood pressure was 170/90 mm 
Hg and ECG revealed a sinus rhythm with normal QT 
intervals. Laboratory tests on admission showed severe 
renal insufficiency with elevated S-urea (202 mg/dL, 
normal = 7-40 mg/dL) and S-creatinine levels (3.1 mg/ 
/dL, normal = 0.80–1.30 mg/dL), hypercalcaemia (22.5 
mg/dL, normal = 8.5–10.1 mg/dL), hypophosphataemia 
(0.55 mg/dL, normal = 2.5–4.50 mg/dL), an increase 
in intact-PTH (1,109 pg/mL, normal = 6.4–52 pg/mL) 
and in 1,25-dihydroxycholecalciferol levels (230.7 pg/ 
/mL, normal = 15.9–55.6 pg/mL). Urine biochemistry 
indicated elevated 24-hour urine calcium excretion (511 
mg/24 h, normal range = 42–353 mg/24 h), phosphate 
clearance (711 mL/min, normal range = 400–1300 mg/24 h) 
and proteinuria (725 mg/24 h, normal range = 0–150 
mg/24 h). Thyroid tests were within normal limits; tu-
mour markers and blood tests for metabolic abnormali-
ties were negative; pancreatic enzymes were normal. 
A cerebral CT scan showed no pathological find-
ings and a diffuse slow activity was revealed by the 
electroencephalogram. 
At first, the patient was treated conservatively with 
aggressive intravenous isotonic chloride infusion, 
furosemide in intravenous dosages from 20–40 mg/d 
once intravascular volume was restored, and 300 mg/d 
of intravenous disodium clodronate tetrahydrate. The 
mental status of the patient gradually improved over 
the next three days and, on the seventh day after the 
initiation of therapy, the calcaemia was 11.7 mg/dL and 
the renal function normalised.
On abdomen ultrasound there was no suspicion of 
kidney stones or nephrocalcinosis and there were no 
signs of pancreatitis. Neck ultrasound demonstrated 
the non-pathological thyroid and an encapsulated 
hypoechoic mass of 1.9 ¥ 1.2 cm in the lower portion 
of the left thyroid lobe. Tc-99m sodium pertechnetate/ 
/Tc-99m-sestamibi parathyroid dual-phase scintigraphy 
with subtraction image technique revealed the mass to 
be a left inferior parathyroid adenoma. 
A minimally invasive radio-guided parathyroid-
ectomy was performed on day 9. One hour before 
surgery, 50 MBq of Tc-99m — sestamibi was injected 
intravenously; in the operating suite, the gamma probe 
(MR-100, 11C, Pol.hi.tech) was used to recognise the 
following: in vivo localisation of the cutaneous pro-
jection of the adenoma; ex vivo uptake of the 2.5 cm 
excised adenoma and, lastly to confirm removal of the 
pathologic parathyroid, on the ‘background’ operated 
area. An apparently normal biopsy of the right inferior 
parathyroid was performed. Intraoperative PTH was 
reduced by more than 50% compared to the normal 
preoperative level. 
Histologically, the tumour consisted of densely 
arranged chief cells with no indication of malignancy 
and immunohistochemically positive for PTH (DakoCy-
tomation; dilution 1:100; mouse) antigens, suggesting 
adenoma. The gland biopsy was normal.
Calcaemia level and PTH were normal in the im-
mediate postoperative period (9 mg/dL and 11 pg/
mL, respectively) and one, six and 12 months after 
surgery (9.2–9–8.8 mg/dL, and 10.5–19–15 pg/mL, 
respectively). 
Recovery was uneventful and the patient was dis-
charged 72 hours after the operation.
Discussion
In 1923, Dawson et al. [6] reported the autopsy of a pa-
tient who died following a syncopal attack, where the 
main features were a parathyroid adenoma, generalised 
osteitis fibrosa and metastatic calcifications. This was 
probably the first case of parathyroid crisis, although 
the authors did not recognise it as such. 
In 1925, the physiologic effects of PTH were studied 
in dogs by Collip, [7] with repeated injections of the 
hormone, causing serum calcium increase, vomiting, 
diarrhoea, atony, coma and death.
In 1932, Lowenberg [8] reported similar evidence 
due to excessive amounts of parathyroid extract for 
the treatment of purpura in a 5 year-old boy. However, 
Wank [9] first described the case of a hyperparathyroid 
crisis due to double parathyroid adenomas treated with 
parathyroidectomy, which pursued an acute and fatal 
course 19 days after the operation.
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This pathological condition, also called parathyro-
toxicosis, acute hyperparathyroidism, parathyroid storm, 
and parathyroid intoxication, or poisoning, is a rare, life-
threatening complication due to a severe increase of 
serum calcium level. There is no standard definition 
for this syndrome [2, 3, 10–24]. Some authors have 
considered patients presenting slight disturbances in 
mental status, lethargy or muscle weakness and serum 
calcium levels around 14 to 16 mg/dL [2, 3, 12–21, 23, 
24], as being affected by hypercalcaemic crisis, whereas 
others included only cases of deep coma [10, 22]. 
Because hypercalcaemic crisis is predominantly 
parathyrotoxic crisis [2–5], PHPT must be confirmed 
or excluded. The reported incidence of hypercalcaemic 
crisis due to PHPT is variable, ranging from 1.6% to 6% 
of patients treated surgically [10, 11, 18, 25], and this 
range includes several defining criteria. Moreover, the 
frequency of the syndrome is modified by the introduc-
tion of PTH radioimmunoassay [26, 27] and of intact-
PTH immunoradiometric assay [28, 29]. 
A systematic review was performed by consulting 
PubMed MEDLINE for publications from 1958 to 2011 
limited to the English language only and matching the 
terms of hypercalcaemic crisis/hyperparathyroid crisis/
parathyroid intoxication/parathyroid storm/parathy-
rotoxicosis/acute hyperparathyroidism/parathyroid 
poisoning AND primary hyperparathyroidism (Table I).
This review found a total of 499 cases, the majority of 
which were women (165 M and 300 F, of whom 20were 
pregnant), while in the remaining 34/499 patients, the 
sex was not reported; the mean age was 43.94 years 
calculated on 424/499 patients, because the age of 75/499 
was not reported. The reported serum calcium average 
was 18 mg/dl (in 460/499 patients).
The table shows that the PTH value was not reported 
before 1978 because hormone assay dates from 1963 [26]. 
Therefore, PTH level was reported in 310/499 cases; it 
was always elevated. 
The commonest symptoms of hypercalcaemic crisis 
are severe nephrolithiasis, constipation, unrelenting 
peptic ulcer disease and osteoporosis. Patients infre-
quently present cardiac arrhythmias and neurocogni-
tive derangements, but, in the literature, this symptom 
is often considered the discriminant factor for definition 
of the disease [2, 3, 10–24]. 
Mental status was reported in 217/499 cases in the 
literature; it was normal in 20.2% of patients only, while 
it was pathological in 173/217 (79.8%). In spite of 50/173 
patients (29%) being in a coma, there were different 
neurological alterations in 123/173 (71%) cases.
There is often no clear reason for the sudden evo-
lution of PHPT to a state of crisis, but in some cases, 
this syndrome is probably precipitated by bacterial or 
viral infection [114], trauma, recent surgery [60, 115], 
and the use of a calcium antagonist [116]. However, 
hypercalcaemic crisis may also occur in the absence of 
any precipitating factor [18].
Surgery was performed in 415/499 patients, while 
treatment with hydration and diuretics was only re-
served in 31/499; in 53/499 cases, the type of treatment 
(surgery or conservative) was not reported. 
There were discordant opinions regarding the tim-
ing of surgery. Some authors suggest an urgent par-
athyroidectomy [3, 13, 14, 18, 23, 24, 68], while others 
propose medical management [2, 5]. 
Standard medical care consists of intravenous iso-
tonic sodium chloride solution in order to obtain the 
intravascular volume expansion, and IV loop diuretics 
to induce calciuresis [2, 3,12, 13, 15, 38, 43]. Hypocal-
caemic drugs, such as bisphosphonates, have also been 
employed as adjuncts to reduce serum calcium levels, 
inhibiting osteoclast function and serving as an effective 
bridge to elective parathyroidectomy [18].
However, medical therapy followed by expeditious 
parathyroidectomy is considered by the majority of 
authors [3, 13, 14, 17, 18, 23, 24, 68] to be the treatment of 
choice for patients affected by hypercalcaemic crisis due 
to PHPT, and this is usually our therapeutic approach, 
as in this reported case.
Histology was reported in 352/499 cases: histologi-
cal examination reveals that the majority of specimens 
were adenoma (85%); the others were multiglandular 
disease (9%) and carcinoma (6%). 
In the literature review, the outcome was reported in 
369/499 cases. Despite the advances in the management of 
hypercalcaemic crisis, the mortality rate is 15.5% (57/369 pa-
tients). The table shows that the mortality was 6.7% (28/415 
reported cases) in surgically treated patients and 93.5% 
(29/31 reported cases) in conservatively treated patients. 
This data is very important in order to confirm the rationale 
of medical therapy followed by quick parathyroidectomy.
Hypercalcaemic crisis remains a rare and potentially 
lethal clinical manifestation of PHPT and it should be 
considered as a dramatic complication of severe hyper-
calcaemia. Multidisciplinary management should be 
performed in order to obtain hydration and diuresis 
and to surgically remove the cause of manifestation. 
Because hypercalcaemic crisis may be the first mani-
festation of PHPT, as in the reported case, we suggest 
that the assay of PTH and imaging of the neck should 
be primarily considered in the diagnostic approach of 
a patient affected by this biochemical abnormality, in 
association with prompt supportive medical therapy. 
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